BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27477323)

  • 1. Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.
    Orth M; Gregory S; Scahill RI; Mayer IS; Minkova L; Klöppel S; Seunarine KK; Boyd L; Borowsky B; Reilmann R; Bernhard Landwehrmeyer G; Leavitt BR; Roos RA; Durr A; Rees G; Rothwell JC; Langbehn D; Tabrizi SJ;
    Hum Brain Mapp; 2016 Dec; 37(12):4615-4628. PubMed ID: 27477323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural biological variation of white matter microstructure is accentuated in Huntington's disease.
    Gregory S; Crawford H; Seunarine K; Leavitt B; Durr A; Roos RAC; Scahill RI; Tabrizi SJ; Rees G; Langbehn D; Orth M
    Hum Brain Mapp; 2018 Sep; 39(9):3516-3527. PubMed ID: 29682858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
    Wu D; Faria AV; Younes L; Mori S; Brown T; Johnson H; Paulsen JS; Ross CA; Miller MI;
    Hum Brain Mapp; 2017 Oct; 38(10):5035-5050. PubMed ID: 28657159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal diffusion changes in prodromal and early HD: Evidence of white-matter tract deterioration.
    Shaffer JJ; Ghayoor A; Long JD; Kim RE; Lourens S; O'Donnell LJ; Westin CF; Rathi Y; Magnotta V; Paulsen JS; Johnson HJ
    Hum Brain Mapp; 2017 Mar; 38(3):1460-1477. PubMed ID: 28045213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor network structure and function are associated with motor performance in Huntington's disease.
    Müller HP; Gorges M; Grön G; Kassubek J; Landwehrmeyer GB; Süßmuth SD; Wolf RC; Orth M
    J Neurol; 2016 Mar; 263(3):539-49. PubMed ID: 26762394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intact sensory-motor network structure and function in far from onset premanifest Huntington's disease.
    Gorges M; Müller HP; Mayer IM; Grupe GS; Kammer T; Grön G; Kassubek J; Landwehrmeyer GB; Wolf RC; Orth M
    Sci Rep; 2017 Mar; 7():43841. PubMed ID: 28266655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
    Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
    Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease.
    Harrington DL; Long JD; Durgerian S; Mourany L; Koenig K; Bonner-Jackson A; Paulsen JS; ; Rao SM
    Mov Disord; 2016 Nov; 31(11):1664-1675. PubMed ID: 27620011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal characterization of the visual network in Huntington's disease gene carriers.
    Gregory S; Odish OFF; Mayer I; Mills J; Johnson EB; Scahill RI; Rothwell J; Rees G; Long JD; Tabrizi SJ; Roos RAC; Orth M
    Clin Neurophysiol; 2019 Nov; 130(11):2053-2059. PubMed ID: 31541982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington's disease.
    Hu B; Younes L; Bu X; Liu CF; Ratnanather JT; Paulsen J; Georgiou-Karistianis N; Miller MI; Ross C; Faria AV
    Neuroimage Clin; 2023; 39():103493. PubMed ID: 37582307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific patterns of brain alterations underlie distinct clinical profiles in Huntington's disease.
    Garcia-Gorro C; Llera A; Martinez-Horta S; Perez-Perez J; Kulisevsky J; Rodriguez-Dechicha N; Vaquer I; Subira S; Calopa M; Muñoz E; Santacruz P; Ruiz-Idiago J; Mareca C; Beckmann CF; de Diego-Balaguer R; Camara E
    Neuroimage Clin; 2019; 23():101900. PubMed ID: 31255947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Changes in Functional Connectivity of Striatum-Prefrontal and Striatum-Motor Circuits in Premanifest Huntington's Disease.
    Kronenbuerger M; Hua J; Bang JYA; Ultz KE; Miao X; Zhang X; Pekar JJ; van Zijl PCM; Duan W; Margolis RL; Ross CA
    Neurodegener Dis; 2019; 19(2):78-87. PubMed ID: 31412344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease.
    Gargouri F; Messé A; Perlbarg V; Valabregue R; McColgan P; Yahia-Cherif L; Fernandez-Vidal S; Ben Hamida A; Benali H; Tabrizi S; Durr A; Lehéricy S
    Hum Brain Mapp; 2016 Nov; 37(11):4112-4128. PubMed ID: 27400836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prefrontal cortex white matter tracts in prodromal Huntington disease.
    Matsui JT; Vaidya JG; Wassermann D; Kim RE; Magnotta VA; Johnson HJ; Paulsen JS;
    Hum Brain Mapp; 2015 Oct; 36(10):3717-32. PubMed ID: 26179962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
    Sweidan W; Bao F; Bozorgzad NS; George E
    J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of selective basal ganglia white matter loss in premanifest Huntington's disease.
    Zeun P; McColgan P; Dhollander T; Gregory S; Johnson EB; Papoutsi M; Nair A; Scahill RI; Rees G; Tabrizi SJ;
    Neuroimage Clin; 2022; 33():102927. PubMed ID: 34999565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking white matter and deep gray matter alterations in premanifest Huntington disease.
    Faria AV; Ratnanather JT; Tward DJ; Lee DS; van den Noort F; Wu D; Brown T; Johnson H; Paulsen JS; Ross CA; Younes L; Miller MI;
    Neuroimage Clin; 2016; 11():450-460. PubMed ID: 27104139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.
    Chen L; Hua J; Ross CA; Cai S; van Zijl PCM; Li X
    J Neurosci Res; 2019 Apr; 97(4):467-479. PubMed ID: 30489648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington's disease: the IMAGE-HD study.
    Tan B; Shishegar R; Oldham S; Fornito A; Poudel G; Georgiou-Karistianis N
    Brain Imaging Behav; 2022 Dec; 16(6):2457-2466. PubMed ID: 35768755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.